Sr. Director, Global New Product Planning: Cardiovascular Gene Editing

Eli Lilly and Company; Indiana; On-site; USD 167,000 - 244,000; Full time

Benefits offered by this job

401(k) with company match

Pension plan

Vacation benefits

Medical, dental, vision benefits

Flexible benefits

Job summary

Verve Therapeutics, a wholly owned subsidiary of Eli Lilly and Company, seeks a Senior Director of Global New Product Planning to shape clinical development and commercial strategy for cardiovascular gene editing. You will bridge research, development and marketing, delivering insights to leadership and driving value for patients, doctors and payers.

The role requires interpreting complex data, working with global teams, and delivering strategic plans in a fast-paced environment.

Qualifications

• Bachelor's degree required.
• Advanced degree preferred (MBA, PhD, PharmD or MS).
• Degree in life sciences.
• Experience in cardiovascular disease, lipid management and/or genetic medicines.
• Experience with forecasting and risk-adjusted valuation.
• Ability to advance work streams with speed in the face of ambiguity.
• Clear written and spoken communication to scientific and non-scientific audiences.

Responsibilities

• Develop expertise on cardiovascular & gene editing market landscapes and socialise learnings with CMH leadership.
• Own asset profiles, value propositions and commercial materials for ASCVD gene editing portfolio.
• Design and run market research to shape strategy across clinical development and commercial planning.
• Shape development plans with discovery, early-phase and late-phase teams from a commercial perspective.
• Engage regions and affiliates to develop a global market view.
• Lead commercial deliverables at development milestones including forecasts and investment recommendations.

Skills

Strategic thinking

Strong communication

Cross-functional collaboration

Education

Bachelor's degree

Advanced degree (MBA, PhD, PharmD or MS)

Life sciences background

Job description

At Lilly, the work is demanding because patients are waiting. We unite caring with discovery to help make life better for people around the world, knowing that every decision, every detail, and every day matters. Headquartered in Indianapolis, Indiana, our over 50,000 employees around the globe take on complex challenges to discover and deliver life-changing medicines, strengthen how health is understood and managed, and support the communities we serve. This is hard, urgent, selfless work—but it’s work worth doing. If you’re driven by purpose and ready to bring your best to work that truly matters for patients, we invite you to join us.

Position Overview

Verve Therapeutics – a wholly owned subsidiary of Eli Lilly and Company – is seeking a Senior Director, Global New Product Planning (NPP) to shape the clinical development and commercial strategy for our cardiovascular gene editing portfolio. NPP is the bridge between our research organization and customers, and in this role, you will work to deliver meaningful experiences for patients while meeting the needs of physicians and payers.

This position requires an “out-of-the-box” thinker who can challenge existing healthcare norms and treatment paradigms. The questions in front of you have not been answered before in a prevalent, chronic disease: What does a target product profile look like for a single-course medicine? What level of evidence will build trust with patients, doctors, regulators, and payers? How should a one‑time therapy be valued against lifelong daily treatment? Is it possible to shape a treatment paradigm oriented around early prevention, rather than delayed intervention?

This high-visibility position collaborates across research, development, and marketing groups in the organization and is responsible for delivering strategic insights to leadership in Lilly’s Cardiometabolic Health (CMH) group. The ideal candidate will excel in a fast‑paced, dynamic environment and possess strong communication skills and attention to detail.

Key Responsibilities

• Develop expertise on the cardiovascular & gene editing market landscapes. Closely monitor relevant competitive efforts. Build a deep understanding of the needs of patients, physicians, and payers. Socialize learnings with CMH leadership & key business partners.
• Own the asset profiles, value propositions, and other key commercial materials for the ASCVD gene editing portfolio and evolve them as data read out. Ensure that these deliverables reflect customer insights and set our assets up for commercial success (beyond registration).
• Partner with market research colleagues to design and run the key market research that will shape strategy across clinical development and commercial planning.
• Partner with discovery, early-phase and late-phase colleagues to shape development plans across the ASCVD gene editing portfolio. Provide the commercial perspective on study design and evidence needs.
• Engage key regions and global affiliates to develop a global view of the market landscape and customer needs.
• Lead the commercial deliverables at each development milestone, including forecasts, risk‑adjusted valuations, and investment recommendations to governance.

Basic Requirements

• Bachelor's degree.
• 5+ years in the pharmaceutical or biotechnology industry in new product planning, commercial strategy, or strategy consulting serving those functions.

Additional Skills & Preferences

• Advanced degree (MBA, PhD, PharmD or MS).
• Degree in life sciences.
• Experience in cardiovascular disease, lipid management and/or genetic medicines.
• Comfort with scientific data and the ability to translate technical insight into commercial implications.
• Experience with forecasting and risk‑adjusted valuation.
• Ability to advance work streams with speed in the face of ambiguity.
• Deep scientific curiosity.
• Proven ability to effectively challenge conventional wisdom at all levels to produce innovative, patient‑oriented solutions.
• Clear written and spoken communication to scientific and non‑scientific audiences.

Lilly is dedicated to helping individuals with disabilities to actively engage in the workforce, ensuring equal opportunities when vying for positions. If you require accommodation to submit a resume for a position at Lilly, please complete the accommodation request form (https://careers.lilly.com/us/en/workplace-accommodation) for further assistance. Please note this is for individuals to request an accommodation as part of the application process and any other correspondence will not receive a response.

Lilly is proud to be an EEO Employer and does not discriminate on the basis of age, race, color, religion, gender identity, sex, gender expression, sexual orientation, genetic information, ancestry, national origin, protected veteran status, disability, or any other legally protected status.

Our employee resource groups (ERGs) offer strong support networks for their members and are open to all employees. Our current groups include: Africa, Middle East, Central Asia (AMECA), Black Employees at Lilly (BE@Lilly), Chinese Culture Network (CCN), EnAble, Evolve, Lilly Indian Network (LIN), Organization of Latinx at Lilly (OLA), Pride (LGBTQ+ Allies), Veterans Leadership Network (VLN) and Women’s Initiative for Leading at Lilly (WILL).

Actual compensation will depend on a candidate’s education, experience, skills, and geographic location. The anticipated wage for this position is $166,500 - $244,200.

Full‑time equivalent employees also will be eligible for a company bonus (depending, in part, on company and individual performance).

• Eligibility to participate in a company-sponsored 401(k).
• Pension.
• Vacation benefits.
• Eligibility for medical, dental, vision and prescription drug benefits.
• Flexible benefits (e.g., healthcare and/or dependent day care flexible spending accounts).
• Life insurance and death benefits.
• Certain time off and leave of absence benefits.
• Well‑being benefits (e.g., employee assistance program, fitness benefits, and employee clubs and activities).

Lilly reserves the right to amend, modify, or terminate its compensation and benefit programs in its sole discretion and Lilly’s compensation practices and guidelines will apply regarding the details of any promotion or transfer of Lilly employees.

#WeAreLilly